Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan
· Delayed Price · Currency is JPY 44.00
+1.00 (2.33%)
Jun 13, 2025, 3:30 PM JST
TYO:4596 Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 29.4 | 27 | 39 | 8 | - | 37 | Upgrade
|
| Revenue Growth (YoY) | -24.62% | -30.77% | 387.50% | - | - | - | Upgrade
|
| Cost of Revenue | 455.15 | 5 | 12 | 5 | - | - | Upgrade
|
| Gross Profit | -425.75 | 22 | 27 | 3 | - | 37 | Upgrade
|
| Selling, General & Admin | 701.58 | 711 | 633 | 602 | 604 | 607 | Upgrade
|
| Research & Development | - | 543 | 788 | 1,512 | 2,040 | 1,972 | Upgrade
|
| Other Operating Expenses | 82.98 | 1 | 110 | - | - | - | Upgrade
|
| Operating Expenses | 784.56 | 1,255 | 1,531 | 2,114 | 2,644 | 2,579 | Upgrade
|
| Operating Income | -1,210 | -1,233 | -1,504 | -2,111 | -2,644 | -2,542 | Upgrade
|
| Interest Expense | -5.66 | -7 | -9 | -11 | -18 | -16 | Upgrade
|
| Interest & Investment Income | 4.18 | 5 | 13 | 18 | 11 | 67 | Upgrade
|
| Other Non Operating Income (Expenses) | 19.9 | 15 | 11 | 89 | 35 | 54 | Upgrade
|
| EBT Excluding Unusual Items | -1,192 | -1,220 | -1,489 | -2,015 | -2,616 | -2,437 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -56 | - | - | - | - | Upgrade
|
| Asset Writedown | -56.8 | -56 | - | - | - | - | Upgrade
|
| Pretax Income | -1,249 | -1,332 | -1,489 | -2,015 | -2,616 | -2,437 | Upgrade
|
| Net Income | -1,249 | -1,332 | -1,489 | -2,015 | -2,616 | -2,437 | Upgrade
|
| Net Income to Common | -1,249 | -1,332 | -1,489 | -2,015 | -2,616 | -2,437 | Upgrade
|
| Shares Outstanding (Basic) | 57 | 56 | 56 | 49 | 46 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 56 | 56 | 49 | 46 | 43 | Upgrade
|
| Shares Change (YoY) | 1.41% | 1.35% | 12.85% | 8.19% | 6.30% | 2.09% | Upgrade
|
| EPS (Basic) | -22.03 | -23.64 | -26.78 | -40.90 | -57.45 | -56.89 | Upgrade
|
| EPS (Diluted) | -22.03 | -23.65 | -26.79 | -40.92 | -57.46 | -56.90 | Upgrade
|
| Free Cash Flow | -1,174 | -1,244 | -1,401 | -2,143 | -2,521 | -2,261 | Upgrade
|
| Free Cash Flow Per Share | -20.71 | -22.08 | -25.20 | -43.50 | -55.36 | -52.78 | Upgrade
|
| Gross Margin | - | 81.48% | 69.23% | 37.50% | - | 100.00% | Upgrade
|
| Operating Margin | -4116.98% | -4566.67% | -3856.41% | -26387.50% | - | -6870.27% | Upgrade
|
| Profit Margin | -4247.51% | -4933.33% | -3817.95% | -25187.50% | - | -6586.49% | Upgrade
|
| Free Cash Flow Margin | -3993.29% | -4607.41% | -3592.31% | -26787.50% | - | -6110.81% | Upgrade
|
| EBITDA | -1,143 | -1,168 | -1,417 | -2,053 | -2,585 | -2,497 | Upgrade
|
| D&A For EBITDA | 67.45 | 65 | 87 | 58 | 59 | 45 | Upgrade
|
| EBIT | -1,210 | -1,233 | -1,504 | -2,111 | -2,644 | -2,542 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.